Shuwen Zhang1, Jingjing Chen1,2, Rui Zhang1, Liqin Xu1, Yan Wang3, Zaixin Yuan1,2, Xiaohui Hou1,2, Jian Feng4. 1. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, 20 Xi-Si Road, Nantong, 226001, Jiangsu, China. 2. Nantong University, Nantong, Jiangsu, China. 3. Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. 4. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, 20 Xi-Si Road, Nantong, 226001, Jiangsu, China. jfeng68@126.com.
Abstract
OBJECTIVE: Pulmonary neuroendocrine tumors (PNETs) consist of small-cell lung cancer (SCLC), large-cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC). We aimed to analyze the immunophenotypic, metastatic, and prognostic risk factors for PNETs. MATERIALS AND METHODS: A total of 266 patients with PNETs were enrolled, including 219 patients with SCLC, 18 patients with LCNEC, 11 patients with TC, and 18 patients with AC. Clinicopathological characteristics and immunophenotypes were compared among the subtypes of PNETs. Risk factors for metastasis, progression-free survival (PFS), and overall survival (OS) were analyzed. RESULTS: Thyroid transcription factor-1 (TTF-1) and the Ki-67 index were significantly different among subtypes of PNETs (all P < 0.05). Smoking (OR, 2.633; P = 0.031), high pretreatment carcinoembryonic antigen (CEA > 5 ng/ml: OR, 3.084; P = 0.014), and poorly differentiated pathotypes (P = 0.001) were independent risk factors for lymph-node metastasis. Smoking (OR, 2.071; P = 0.027) and high pretreatment CEA (OR, 2.260; P = 0.007) were independent risk factors for distant metastasis. Results of the multivariate Cox regression model showed pretreatment CEA (HR, 1.674; P = 0.008) and lymphocyte-monocyte ratio (LMR) (HR = 0.478, P = 0.007) were significantly associated with PFS; BMI (P = 0.031), lymph-node metastasis (HR = 4.534, P = 0.001), poorly differentiated pathotypes (P = 0.015), platelet-lymphocyte ratio (PLR) (HR = 2.305, P = 0.004), and LMR (HR = 0.524, P = 0.045) were significantly associated with OS. CONCLUSIONS: PNETs are a group of highly heterogeneous tumors with different clinical manifestations, pathological features, and prognoses. Knowing clinicopathological characteristics and immunophenotypes of PNETs is significant for diagnosis. Pretreatment PLR, LMR, and CEA have certain value in the prognosis of PNETs.
OBJECTIVE: Pulmonary neuroendocrine tumors (PNETs) consist of small-cell lung cancer (SCLC), large-cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC). We aimed to analyze the immunophenotypic, metastatic, and prognostic risk factors for PNETs. MATERIALS AND METHODS: A total of 266 patients with PNETs were enrolled, including 219 patients with SCLC, 18 patients with LCNEC, 11 patients with TC, and 18 patients with AC. Clinicopathological characteristics and immunophenotypes were compared among the subtypes of PNETs. Risk factors for metastasis, progression-free survival (PFS), and overall survival (OS) were analyzed. RESULTS: Thyroid transcription factor-1 (TTF-1) and the Ki-67 index were significantly different among subtypes of PNETs (all P < 0.05). Smoking (OR, 2.633; P = 0.031), high pretreatment carcinoembryonic antigen (CEA > 5 ng/ml: OR, 3.084; P = 0.014), and poorly differentiated pathotypes (P = 0.001) were independent risk factors for lymph-node metastasis. Smoking (OR, 2.071; P = 0.027) and high pretreatment CEA (OR, 2.260; P = 0.007) were independent risk factors for distant metastasis. Results of the multivariate Cox regression model showed pretreatment CEA (HR, 1.674; P = 0.008) and lymphocyte-monocyte ratio (LMR) (HR = 0.478, P = 0.007) were significantly associated with PFS; BMI (P = 0.031), lymph-node metastasis (HR = 4.534, P = 0.001), poorly differentiated pathotypes (P = 0.015), platelet-lymphocyte ratio (PLR) (HR = 2.305, P = 0.004), and LMR (HR = 0.524, P = 0.045) were significantly associated with OS. CONCLUSIONS: PNETs are a group of highly heterogeneous tumors with different clinical manifestations, pathological features, and prognoses. Knowing clinicopathological characteristics and immunophenotypes of PNETs is significant for diagnosis. Pretreatment PLR, LMR, and CEA have certain value in the prognosis of PNETs.
Authors: Niccolò Daddi; Marco Schiavon; Pier Luigi Filosso; Giuseppe Cardillo; Marcello Carlo Ambrogi; Angela De Palma; Luca Luzzi; Alessandro Bandiera; Christian Casali; Alberto Ruffato; Verena De Angelis; Luigi Gaetano Andriolo; Francesco Guerrera; Francesco Carleo; Federico Davini; Moira Urbani; Sandro Mattioli; Uliano Morandi; Piero Zannini; Giuseppe Gotti; Michele Loizzi; Francesco Puma; Alfredo Mussi; Alberto Ricci; Alberto Oliaro; Federico Rea Journal: Eur J Cardiothorac Surg Date: 2013-10-06 Impact factor: 4.191
Authors: Jules Derks; Robert Jan van Suylen; Erik Thunnissen; Michael den Bakker; Harry Groen; Egbert Smit; Ronald Damhuis; Esther van den Broek; Ernst-Jan Speel; Anne-Marie C Dingemans Journal: Eur Respir J Date: 2017-10-26 Impact factor: 16.671
Authors: Lynnette Fernandez-Cuesta; Ernst-Jan M Speel; Anne-Marie C Dingemans; Jules L Derks; Noémie Leblay; Erik Thunnissen; Robert Jan van Suylen; Michael den Bakker; Harry J M Groen; Egbert F Smit; Ronald Damhuis; Esther C van den Broek; Amélie Charbrier; Matthieu Foll; James D McKay Journal: Clin Cancer Res Date: 2017-10-24 Impact factor: 12.531
Authors: Kevin L Anderson; Michael S Mulvihill; Paul J Speicher; Babatunde A Yerokun; Brian C Gulack; Daniel P Nussbaum; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2017-07-29 Impact factor: 4.330
Authors: Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777
Authors: A-M C Dingemans; M Früh; A Ardizzoni; B Besse; C Faivre-Finn; L E Hendriks; S Lantuejoul; S Peters; N Reguart; C M Rudin; D De Ruysscher; P E Van Schil; J Vansteenkiste; M Reck Journal: Ann Oncol Date: 2021-04-20 Impact factor: 51.769